BACKGROUND: As the role of palliative care (PC) has yet to be clearly defined in patients with heart failure (HF), such patients may face barriers regarding PC referral. In order to maximally meet the needs of HF patients, it is necessary to understand how they compare to the classic PC population: patients with cancer. OBJECTIVE: To characterize the unresolved symptom and treatment needs with which patients with HF and those with cancer present to PC. METHODS: We used data from the Palliative Care Research Registry (PCRR), a repository of quality improvement data from three community-based PC organizations. We abstracted first PC visit data from the PCRR for patients with primary diagnoses of HF or cancer seen between 2008 and 2012. We assessed the association of primary diagnosis (i.e., HF or cancer) on three outcomes: unresolved symptoms, treatment gaps, and a composite indicator of symptom control and quality of life. Analyses included descriptive statistics and multivariate Poisson regression. RESULTS: Our analytic sample comprised 334 patients with HF and 697 patients with cancer, the majority of whom were white and male. Compared to patients with cancer, patients with HF presented with fewer unresolved symptoms, both overall and at moderate/severe distress levels. Patients with HF more commonly reported moderately/severely distressful dyspnea (25% versus 18%, p=0.02), and more commonly experienced dyspnea-related treatment gaps (17% versus 8%, p<0.001). CONCLUSIONS: Patients with HF possess care needs that are squarely within the purview of PC. Future work is needed to delineate how PC referral policies should be refined to optimize PC access for patients with HF.
BACKGROUND: As the role of palliative care (PC) has yet to be clearly defined in patients with heart failure (HF), such patients may face barriers regarding PC referral. In order to maximally meet the needs of HF patients, it is necessary to understand how they compare to the classic PC population: patients with cancer. OBJECTIVE: To characterize the unresolved symptom and treatment needs with which patients with HF and those with cancer present to PC. METHODS: We used data from the Palliative Care Research Registry (PCRR), a repository of quality improvement data from three community-based PC organizations. We abstracted first PC visit data from the PCRR for patients with primary diagnoses of HF or cancer seen between 2008 and 2012. We assessed the association of primary diagnosis (i.e., HF or cancer) on three outcomes: unresolved symptoms, treatment gaps, and a composite indicator of symptom control and quality of life. Analyses included descriptive statistics and multivariate Poisson regression. RESULTS: Our analytic sample comprised 334 patients with HF and 697 patients with cancer, the majority of whom were white and male. Compared to patients with cancer, patients with HF presented with fewer unresolved symptoms, both overall and at moderate/severe distress levels. Patients with HF more commonly reported moderately/severely distressful dyspnea (25% versus 18%, p=0.02), and more commonly experienced dyspnea-related treatment gaps (17% versus 8%, p<0.001). CONCLUSIONS:Patients with HF possess care needs that are squarely within the purview of PC. Future work is needed to delineate how PC referral policies should be refined to optimize PC access for patients with HF.
Authors: Arif H Kamal; Janet Bull; Dio Kavalieratos; Donald H Taylor; William Downey; Amy P Abernethy Journal: J Oncol Pract Date: 2011-11 Impact factor: 3.840
Authors: Megan Bannon; Natalie C Ernecoff; J Nicholas Dionne-Odom; Camilla Zimmermann; Jennifer Corbelli; Michele Klein-Fedyshin; Robert M Arnold; Yael Schenker; Dio Kavalieratos Journal: J Palliat Med Date: 2019-02-14 Impact factor: 2.947
Authors: Arif H Kamal; Janet Bull; Dio Kavalieratos; Jonathan M Nicolla; Laura Roe; Martha Adams; Amy P Abernethy Journal: J Palliat Med Date: 2016-06-27 Impact factor: 2.947
Authors: John G Cagle; Morgan Bunting; Anne Kelemen; Joonyup Lee; Dorothy Terry; Ryan Harris Journal: Heart Fail Rev Date: 2017-09 Impact factor: 4.214
Authors: Laura P Gelfman; Dio Kavalieratos; Winifred G Teuteberg; Anuradha Lala; Nathan E Goldstein Journal: Heart Fail Rev Date: 2017-09 Impact factor: 4.214
Authors: Kieran L Quinn; Mohammed Shurrab; Kevin Gitau; Dio Kavalieratos; Sarina R Isenberg; Nathan M Stall; Therese A Stukel; Russell Goldman; Daphne Horn; Peter Cram; Allan S Detsky; Chaim M Bell Journal: JAMA Date: 2020-10-13 Impact factor: 56.272
Authors: Dio Kavalieratos; Laura P Gelfman; Laura E Tycon; Barbara Riegel; David B Bekelman; Dara Z Ikejiani; Nathan Goldstein; Stephen E Kimmel; Marie A Bakitas; Robert M Arnold Journal: J Am Coll Cardiol Date: 2017-10-10 Impact factor: 24.094
Authors: Michael J Bonares; Ken Mah; Jane MacIver; Lindsay Hurlburt; Ebru Kaya; Gary Rodin; Heather Ross; Camilla Zimmermann; Kirsten Wentlandt Journal: CJC Open Date: 2020-12-09
Authors: Shelli L Feder; Janet Tate; Mary Ersek; Supriya Krishnan; Sarwat I Chaudhry; Lori A Bastian; Joshua Rolnick; Ann Kutney-Lee; Kathleen M Akgün Journal: J Pain Symptom Manage Date: 2020-09-12 Impact factor: 3.612
Authors: Brett R Curtis; Bruce L Rollman; Bea Herbeck Belnap; Kwonho Jeong; Lan Yu; Matthew E Harinstein; Dio Kavalieratos Journal: J Pain Symptom Manage Date: 2021-06-11 Impact factor: 3.612